Conjugated linoleic acid suppresses dendritic cell activation and subsequent Th17 responses

Journal of Nutritional Biochemistry

Volumn 25, Issue 7, 2014, Pages 741-749

  Draper, Eve ^a   DeCourcey, Joseph ^a   Higgins, Sarah C ^b   Canavan, Mary ^a   McEvoy, Fiona ^a   Lynch, Mark ^a   Keogh, Brian ^b   Reynolds, Clare ^c   Roche, Helen M ^c   Mills, Kingston H G ^b   Loscher, Christine E ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Conjugated linoleic acid; Dendritic cell; Th1; Th17

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CONJUGATED LINOLEIC ACID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA; 9,11-LINOLEIC ACID; EDIBLE OIL;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; SEPTIC SHOCK; TH17 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; C57BL MOUSE; DRUG EFFECTS; IMMUNOLOGY; TOXICITY;

ANIMALS; CELL DIFFERENTIATION; DENDRITIC CELLS; DIETARY FATS, UNSATURATED; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-1BETA; LINOLEIC ACIDS, CONJUGATED; LIPOPOLYSACCHARIDES; MICE, INBRED BALB C; MICE, INBRED C57BL; TH17 CELLS;

EID: 84901856464     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.03.004     Document Type: Article

References (45)

1. Roche H.M., Noone E., Sewter C., Bennett S.M., Savage D., Gibney M.J., et al. Isomer-dependent metabolic effects of conjugated linoleic acid. Diabetes 2002, 51:2037-2044.
2. O'Shea M., Bassaganya-Riera J., Mohede I.C.M. Immunomodulatory properties of conjugated linoleic acid. Am J Clin Nutr 2004, 79:1199S-1206S.
3. Miller C.C., Park Y., Pariza M.W., Cook M.E. Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem Biophys Res Commun 1994, 198:1107-1112.
4. Hontecillas R., Wannemeulher M.J., Zimmerman D.R., Hutto D.L., Wilson J.H., Ahn D.U., et al. Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid. J Nutr 2002, 132:2019-2027.
5. Bregendahl K., Wannemuehler M.J. Effects of dietary conjugated linoleic acid in nursery pigs of dirty and clean environments on growth, empty body composition, and immune competence. J Anim Sci 2001, 79:714-721.
6. Loscher C.E., Draper E., Leavy O., Kelleher D., Mills K.H.G., Roche H.M. Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J Immunol 2005, 175:4990-4998.
7. Kikly K., Liu L., Na S., Sedgwick J.D. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 2006, 18:670-675.
8. De Jong E.C., Smits H.H., Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol 2005, 26:289-307.
9. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004, 202:96-105.
10. McGuirk P., Mills K.H. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol 2000, 30:415-422.
11. Agnello D., Lankford C.S.R., Bream J., Morinobu A., Gadina M., O'Shea J.J., et al. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 2003, 23:147-161.
12. Kolls J.K., Linde A. Interleukin-17 family members. Immunity 2004, 21:467-476.
13. Harrington L.E., Mangan P.R., Weaver C.T. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006, 18:349-356.
14. Bi Y., Liu G., Yang R. Th17 cell induction and immune regulatory effects. J Cell Physiol 2007, 211:273-278.
15. Bettelli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007, 8:345-350.
16. Sutton C., Brereton C., Keogh B., Mills K.H.G., Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006, 203:1685-1691.
17. Kelley D.S., Taylor P.C., Rudolph I.L., Benito P., Nelson G.J., Mackey B.E., et al. Dietary conjugated linoleic acid did not alter immune status in young healthy women. Lipids 2000, 35:1065-1071.
18. Bassaganya-Riera J., Hontecillas R., Horne W.T., Sandridge M., Herfarth H.H., Bloomfeld R., et al. Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn's disease. Clin Nutr 2012, 31:721-727.
19. Dowling J.K., McCoy C.E., Doyle S.L., BenLarbi N., Canavan M., O'Neill L.A. Conjugated linoleic acid suppresses IRF3 activation via modulation of CD14. J Nutr Biochem 2013, 24:920-928.
20. Weatherill A.R., Lee J.Y., Zhao L., Danielle G., Youn H.S., Hwang D.H., et al. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol 2005, 174:5390-5397.
21. Sallusto F., Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000, 177:134-140.
22. Bassaganya-Riera Josep, Hontecillas Raquel Dietary CLA and n-3 PUFA in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2011, 13:569-573.
23. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
24. Haskó G., Szabó C. IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses. Br J Pharmacol 1999, 127:1295-1304.
25. Papadakis K.A., Targan S.R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000, 289-298.
26. Fuss I.J., Becker C., Yang Z., Groden C., Hornung R.L., Heller F., et al. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm Bowel Dis 2006, 12:9-15.
27. Batten M., Ghilardi N. The biology and therapeutic potential of interleukin 27. J Mol Med (Berl) 2007, 85:661-672.
28. Smith-garvin J.E., Koretzky G.A., Jordan M.S. T cell activation. Annu Rev Immunol 2009, 27:591-619.
29. Yessoufou A., Plé A., Moutairou K., Hichami A., Khan N.A. Docosahexaenoic acid reduces suppressive and migratory functions of CD4+CD25+ regulatory T-cells. J Lipid Res 2009, 50:2377-2388.
30. Sanderson P. Dietary fish oil diminishes the antigen presentation activity of rat dendritic cells. J Leukoc 1997, 62:771-777.
31. Hughes D.A., Pinder A.C. n-3 Polyunsaturated fatty acids inhibit the antigen-presenting function of human monocytes. Am J Clin Nutr 2000, 71:357S-360S.
32. Bhatia S., Edidin M., Almo S.C., Nathenson S.G. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol Lett 2006, 104:70-75.
33. Wang H., Hao Q., Li Q.-R., Yan X.-W., Ye S., Li Y.-S., et al. Omega-3 polyunsaturated fatty acids affect lipopolysaccharide-induced maturation of dendritic cells through mitogen-activated protein kinases p38. Nutrition 2007, 23:474-482.
34. Rugtveit J., Bakka A., Brandtzaeg P. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin Exp Immunol 1997, 110:104-113.
35. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N., Cuzner M.L., et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995, 182:1985-1996.
36. Maerten P., Liu Z., Ceuppens J.L. Targeting of costimulatory molecules as a therapeutic approach in inflammatory bowel disease. BioDrugs 2003, 17:395-411.
37. Eri R., Kodumudi K.N., Summerlin D.J., Srinivasan M. Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:458-470.
38. Corinti S., Albanesi C., la Sala A., Pastore S., Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001, 166:4312-4318.
39. McBride J.M., Jung T., de Vries J.E., Aversa G. IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell Immunol 2002, 215:162-172.
40. Bastos K.R.B., Marinho C.R.F., Barboza R., Russo M., Alvarez J.M., D'Império Lima M.R. What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells?. Microbes Infect 2004, 6:630-636.
41. Szabo S.J., Sullivan B.M., Peng S.L., Glimcher L.H. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 2003, 21:713-758.
42. Nakamura K., Honda K., Mizutani T., Akiho H., Harada N. Novel strategies for the treatment of inflammatory bowel disease: selective inhibition of cytokines and adhesion molecules. World J Gastroenterol 2006, 12:4628-4635.
43. Zhang Z., Zheng M., Bindas J., Schwarzenberger P., Kolls J.K. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006, 12:382-388.
44. Kong W., Yen J.-H., Ganea D. Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Brain Behav Immun 2011, 25:872-882.
45. Haworth O., Cernadas M., Yang R., Serhan C.N., Levy B.D. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 2008, 9:873-879.